Medipharm Labs provides information on three Apollo Capital nominees
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 23 2025
0mins
Should l Buy ?
MediPharm Labs Shareholder Meeting: MediPharm Labs informed shareholders about three directors nominated by Apollo Technology Capital Corporation for election at the upcoming Annual and Special Meeting on June 16, 2025, expressing concerns over their past actions at Check-Cap.
Concerns Over Governance: The company highlighted issues of poor governance, lack of transparency, and questionable financial practices at Check-Cap, urging shareholders to be cautious about voting for nominees associated with Regan McGee.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
